APEH
Acylamino-acid-releasing enzyme
Also known as: ACPH_HUMAN, D3F15S2, D3S48E, DNF15S2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P13798
- Gene
- APEH
- Ensembl
- ENSG00000164062
- Chromosome
- 3
- Canonical length
- 732 aa
- Protein class
- Enzymes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Cytosol
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
This gene encodes the enzyme acylpeptide hydrolase, which catalyzes the hydrolysis of the terminal acetylated amino acid preferentially from small acetylated peptides. The acetyl amino acid formed by this hydrolase is further processed to acetate and a free amino acid by an aminoacylase. This gene is located within the same region of chromosome 3 (3p21) as the aminoacylase gene, and deletions at this locus are also associated with a decrease in aminoacylase activity. The acylpeptide hydrolase is a homotetrameric protein of 300 kDa with each subunit consisting of 732 amino acid residues. It can play an important role in destroying oxidatively damaged proteins in living cells. Deletions of this gene locus are found in various types of carcinomas, including small cell lung carcinoma and renal cell carcinoma. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
732 residues, UniProt reviewed canonical sequence.
>P13798|APEH
1 MERQVLLSEP EEAAALYRGL SRQPALSAAC LGPEVTTQYG GQYRTVHTEW TQRDLERMEN
61 IRFCRQYLVF HDGDSVVFAG PAGNSVETRG ELLSRESPSG TMKAVLRKAG GTGPGEEKQF
121 LEVWEKNRKL KSFNLSALEK HGPVYEDDCF GCLSWSHSET HLLYVAEKKR PKAESFFQTK
181 ALDVSASDDE IARLKKPDQA IKGDQFVFYE DWGENMVSKS IPVLCVLDVE SGNISVLEGV
241 PENVSPGQAF WAPGDAGVVF VGWWHEPFRL GIRFCTNRRS ALYYVDLIGG KCELLSDDSL
301 AVSSPRLSPD QCRIVYLQYP SLIPHHQCSQ LCLYDWYTKV TSVVVDVVPR QLGENFSGIY
361 CSLLPLGCWS ADSQRVVFDS AQRSRQDLFA VDTQVGTVTS LTAGGSGGSW KLLTIDQDLM
421 VAQFSTPSLP PTLKVGFLPS AGKEQSVLWV SLEEAEPIPD IHWGIRVLQP PPEQENVQYA
481 GLDFEAILLQ PGSPPDKTQV PMVVMPHGGP HSSFVTAWML FPAMLCKMGF AVLLVNYRGS
541 TGFGQDSILS LPGNVGHQDV KDVQFAVEQV LQEEHFDASH VALMGGSHGG FISCHLIGQY
601 PETYRACVAR NPVINIASML GSTDIPDWCV VEAGFPFSSD CLPDLSVWAE MLDKSPIRYI
661 PQVKTPLLLM LGQEDRRVPF KQGMEYYRAL KTRNVPVRLL LYPKSTHALS EVEVESDSFM
721 NAVLWLRTHL GSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against APEH can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 97 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 97 nTPM
- tongue: 97 nTPM
- kidney: 61 nTPM
- liver: 59 nTPM
- parathyroid gland: 59 nTPM
- rectum: 49 nTPM
Single-cell type
- cytotrophoblasts: 100 nCPM
- migrating cytotrophoblasts: 85 nCPM
- colonocytes: 80 nCPM
- hepatocytes: 80 nCPM
- enterocytes: 76 nCPM
- esophageal suprabasal cells: 76 nCPM
Immune cell
- basophil: 58 nTPM
- eosinophil: 53 nTPM
- total PBMC: 52 nTPM
- T-reg: 51 nTPM
- non-classical monocyte: 48 nTPM
- intermediate monocyte: 48 nTPM
Brain region
- choroid plexus: 55 nTPM
- pons: 48 nTPM
- midbrain: 42 nTPM
- hypothalamus: 38 nTPM
- thalamus: 38 nTPM
- medulla oblongata: 37 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.83
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.21
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Peptidase S9, prolyl oligopeptidase, catalytic domain
- Peptidase S9, serine active site
- Six-bladed beta-propeller, TolB-like
- Alpha/Beta hydrolase fold
- Prolyl oligopeptidase family
- Acylamino-acid-releasing enzyme, N-terminal domain
- Acylamino-acid-releasing enzyme, N-terminal domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads APEH as an antibody target. Whether an autoantibody or antibody against APEH could matter depends on whether native APEH is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
APEH is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label APEH as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...